Legal & General Group PLC Cin Cor Pharma, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$10.75 - $29.84 $8,707 - $24,170	810 Added 13.26%	6,919 $85,000
Q3 2022 Nov 14, 2022	BUY	$19.9 - $38.94 $35,322 - $69,118	1,775 Added 40.96%	6,109 $200,000
Q2 2022 Aug 22, 2022	BUY	$13.67 - $25.74 $44,167 - $83,165	3,231 Added 292.93%	4,334 $81,000
Q1 2022 May 16, 2022	BUY	$14.13 - $28.49 $15,585 - $31,424	1,103 New	1,103 $19,000

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.